Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.
Clinical trial NCT05156723 · COMPLETED
Trial details
- NCT number
- NCT05156723
- Sponsor
- St. Petersburg Research Institute of Vaccines and Sera
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2021-08-30
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.